Copyright Reports & Markets. All rights reserved.

Global DTaP and Tdap Vaccines Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 DTaP and Tdap Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key DTaP and Tdap Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Type
    • 1.4.2 DTaP
    • 1.4.3 Td
    • 1.4.4 Tdap
  • 1.5 Market by Application
    • 1.5.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Application
    • 1.5.2 Adult
    • 1.5.3 Pediatric
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global DTaP and Tdap Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global DTaP and Tdap Vaccines Revenue 2015-2026
    • 2.1.2 Global DTaP and Tdap Vaccines Sales 2015-2026
  • 2.2 Global DTaP and Tdap Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global DTaP and Tdap Vaccines Competitor Landscape by Players

  • 3.1 DTaP and Tdap Vaccines Sales by Manufacturers
    • 3.1.1 DTaP and Tdap Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 DTaP and Tdap Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 DTaP and Tdap Vaccines Revenue by Manufacturers
    • 3.2.1 DTaP and Tdap Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global DTaP and Tdap Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by DTaP and Tdap Vaccines Revenue in 2019
    • 3.2.5 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 DTaP and Tdap Vaccines Price by Manufacturers
  • 3.4 DTaP and Tdap Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 DTaP and Tdap Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers DTaP and Tdap Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global DTaP and Tdap Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global DTaP and Tdap Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global DTaP and Tdap Vaccines Revenue by Type (2015-2020)
    • 4.1.3 DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global DTaP and Tdap Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 DTaP and Tdap Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global DTaP and Tdap Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global DTaP and Tdap Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global DTaP and Tdap Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global DTaP and Tdap Vaccines Revenue by Application (2015-2020)
    • 5.1.3 DTaP and Tdap Vaccines Price by Application (2015-2020)
  • 5.2 DTaP and Tdap Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global DTaP and Tdap Vaccines Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America DTaP and Tdap Vaccines by Country
    • 6.1.1 North America DTaP and Tdap Vaccines Sales by Country
    • 6.1.2 North America DTaP and Tdap Vaccines Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America DTaP and Tdap Vaccines Market Facts & Figures by Type
  • 6.3 North America DTaP and Tdap Vaccines Market Facts & Figures by Application

7 Europe

  • 7.1 Europe DTaP and Tdap Vaccines by Country
    • 7.1.1 Europe DTaP and Tdap Vaccines Sales by Country
    • 7.1.2 Europe DTaP and Tdap Vaccines Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe DTaP and Tdap Vaccines Market Facts & Figures by Type
  • 7.3 Europe DTaP and Tdap Vaccines Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific DTaP and Tdap Vaccines by Region
    • 8.1.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region
    • 8.1.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Type
  • 8.3 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America DTaP and Tdap Vaccines by Country
    • 9.1.1 Latin America DTaP and Tdap Vaccines Sales by Country
    • 9.1.2 Latin America DTaP and Tdap Vaccines Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America DTaP and Tdap Vaccines Market Facts & Figures by Type
  • 9.3 Central & South America DTaP and Tdap Vaccines Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa DTaP and Tdap Vaccines by Country
    • 10.1.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
    • 10.1.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Type
  • 10.3 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi Pasteur
    • 11.1.1 Sanofi Pasteur Corporation Information
    • 11.1.2 Sanofi Pasteur Description and Business Overview
    • 11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
    • 11.1.5 Sanofi Pasteur Related Developments
  • 11.2 GlaxoSmithKline
    • 11.2.1 GlaxoSmithKline Corporation Information
    • 11.2.2 GlaxoSmithKline Description and Business Overview
    • 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
    • 11.2.5 GlaxoSmithKline Related Developments
  • 11.3 Protein Sciences Corporation
    • 11.3.1 Protein Sciences Corporation Corporation Information
    • 11.3.2 Protein Sciences Corporation Description and Business Overview
    • 11.3.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
    • 11.3.5 Protein Sciences Corporation Related Developments
  • 11.4 Novartis AG
    • 11.4.1 Novartis AG Corporation Information
    • 11.4.2 Novartis AG Description and Business Overview
    • 11.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
    • 11.4.5 Novartis AG Related Developments
  • 11.5 Seqirus
    • 11.5.1 Seqirus Corporation Information
    • 11.5.2 Seqirus Description and Business Overview
    • 11.5.3 Seqirus Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
    • 11.5.5 Seqirus Related Developments
  • 11.6 Merck Sharp & Dohme Corp
    • 11.6.1 Merck Sharp & Dohme Corp Corporation Information
    • 11.6.2 Merck Sharp & Dohme Corp Description and Business Overview
    • 11.6.3 Merck Sharp & Dohme Corp Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
    • 11.6.5 Merck Sharp & Dohme Corp Related Developments
  • 11.7 Astellas Pharma US, Inc
    • 11.7.1 Astellas Pharma US, Inc Corporation Information
    • 11.7.2 Astellas Pharma US, Inc Description and Business Overview
    • 11.7.3 Astellas Pharma US, Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
    • 11.7.5 Astellas Pharma US, Inc Related Developments
  • 11.8 Pfizer Inc
    • 11.8.1 Pfizer Inc Corporation Information
    • 11.8.2 Pfizer Inc Description and Business Overview
    • 11.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
    • 11.8.5 Pfizer Inc Related Developments
  • 11.9 Johnson & Johnson
    • 11.9.1 Johnson & Johnson Corporation Information
    • 11.9.2 Johnson & Johnson Description and Business Overview
    • 11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
    • 11.9.5 Johnson & Johnson Related Developments
  • 11.10 Lanzhou Institute of Biological Products Co., Ltd
    • 11.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
    • 11.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
    • 11.10.3 Lanzhou Institute of Biological Products Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
    • 11.10.5 Lanzhou Institute of Biological Products Co., Ltd Related Developments
  • 11.1 Sanofi Pasteur
    • 11.1.1 Sanofi Pasteur Corporation Information
    • 11.1.2 Sanofi Pasteur Description and Business Overview
    • 11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
    • 11.1.5 Sanofi Pasteur Related Developments
  • 11.12 Emergent BioSolutions Inc
    • 11.12.1 Emergent BioSolutions Inc Corporation Information
    • 11.12.2 Emergent BioSolutions Inc Description and Business Overview
    • 11.12.3 Emergent BioSolutions Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Emergent BioSolutions Inc Products Offered
    • 11.12.5 Emergent BioSolutions Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 DTaP and Tdap Vaccines Market Estimates and Projections by Region
    • 12.1.1 Global DTaP and Tdap Vaccines Sales Forecast by Regions 2021-2026
    • 12.1.2 Global DTaP and Tdap Vaccines Revenue Forecast by Regions 2021-2026
  • 12.2 North America DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
    • 12.2.1 North America: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
    • 12.2.2 North America: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
    • 12.2.3 North America: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)
  • 12.3 Europe DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
    • 12.3.1 Europe: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
    • 12.3.2 Europe: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
    • 12.3.3 Europe: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: DTaP and Tdap Vaccines Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
    • 12.5.2 Latin America: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key DTaP and Tdap Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 DTaP and Tdap Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    DTaP and Tdap Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global DTaP and Tdap Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the DTaP and Tdap Vaccines market is segmented into
    DTaP
    Td
    Tdap

    Segment by Application, the DTaP and Tdap Vaccines market is segmented into
    Adult
    Pediatric

    Regional and Country-level Analysis
    The DTaP and Tdap Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the DTaP and Tdap Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and DTaP and Tdap Vaccines Market Share Analysis
    DTaP and Tdap Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in DTaP and Tdap Vaccines business, the date to enter into the DTaP and Tdap Vaccines market, DTaP and Tdap Vaccines product introduction, recent developments, etc.

    The major vendors covered:
    Sanofi Pasteur
    GlaxoSmithKline
    Protein Sciences Corporation
    Novartis AG
    Seqirus
    Merck Sharp & Dohme Corp
    Astellas Pharma US, Inc
    Pfizer Inc
    Johnson & Johnson
    Lanzhou Institute of Biological Products Co., Ltd
    AstraZeneca
    Emergent BioSolutions Inc

    Buy now